Prof. Chen Liu 刘辰
Chief Physician, Professor
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Laparoscopic pancreatic, hepatobiliary, and gallbladder surgery; organ-preserving procedures for benign and low-grade malignant tumors; surgical treatment of pancreatic neuroendocrine tumors, duodenal, retroperitoneal, and liver tumors; comprehensive care for advanced pancreatic cancer.
Dr. Liu holds a PhD in Surgery from Fudan University and serves as Deputy Director of the Pancreatic Surgery Department at Fudan University Shanghai Cancer Center. Trained under Professor Ni Quanxing, Dr. Liu has nearly 20 years of experience in clinical care and research on the tumor microenvironment of pancreatic and hepatobiliary cancers.
Professional roles
- Expert Committee Member, Robotic Surgery Expert Working Group, Surgical Branch of Chinese Medical Doctor Association
- Deputy Leader, Multi-regional Diagnosis and Treatment Group, Pancreatic Cancer Professional Committee, Shanghai Anti-Cancer Association
- Secretary and Committee Member, Minimally Invasive Diagnosis and Treatment Group, Pancreatic Cancer Professional Committee, China Anti-Cancer Association
- Secretary and Committee Member, Youth Group, Pancreatic Cancer Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Liu Chen). Papers usually list the name as Chen Liu or Liu C.
Selected publications
111 papers on PubMed matched by name and affiliation; 31 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Surg, 2025 (first author): Effect of Laparoscopic Versus Open Distal Pancreatectomy on Recurrence-free Survival in Patients With Left-sided Pancreatic Cancer: A Randomized Controlled Trial. PubMed 39996303
- Biochim Biophys Acta Mol Basis Dis, 2024 (senior author): BCL6 overexpression in CD4(+) T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancer. PubMed 38986820
- Cancer Immunol Immunother, 2024 (senior author): DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer. PubMed 39110249
- Cancer Immunol Immunother, 2024 (senior author): Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma. PubMed 38430267
- J Immunother Cancer, 2023 (senior author): Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance. PubMed 37364934
- Hepatobiliary Pancreat Dis Int, 2023 (senior author): Laparoscopic pancreaticoduodenectomy with portal or superior mesenteric vein resection and reconstruction for pancreatic cancer: A single-center experience. PubMed 36690522
- Discov Oncol, 2023 (first author): Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer. PubMed 36797531
- Cancers (Basel), 2023 (senior author): Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures. PubMed 36765788
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion